Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Registry Of Clinical Trials Proposed By AMA To Limit Publication Bias

Executive Summary

The American Medical Association is calling on HHS to create a registry of all clinical trials to help ensure publication of negative findings

You may also be interested in...



ClinicalTrials.gov Postings Should Include Studies For All Diseases – PhRMA

PhRMA member companies are committing to posting clinical study information on the ClinicalTrials.gov database for all diseases and conditions, not only for those that are "serious or life-threatening.

ClinicalTrials.gov Postings Should Include Studies For All Diseases – PhRMA

PhRMA member companies are committing to posting clinical study information on the ClinicalTrials.gov database for all diseases and conditions, not only for those that are "serious or life-threatening.

DTC Ads Should Be Better, Not Banned, In Wake Of Vioxx, Ex-FDAer Pitts Says

The response to the Vioxx withdrawal offers further evidence of the need for FDA and manufacturers to modify the "brief summary" requirement in direct-to-consumer ads, former Associate Commissioner for External Relations Peter Pitts said during a Nov. 10 Drug & Device Dialogue audio conference sponsored by F-D-C Reports and Polidais LLC

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS044201

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel